Tumor vaccine with chemo for metastatic pancreatic cancer
Part of Cancer clinical trials.
This trial tests a new tumor vaccine combined with standard chemotherapy for people with pancreatic cancer that has spread. The vaccine aims to help your immune system fight the cancer, and the chemo helps shrink tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have pancreatic cancer that has spread and cannot be removed with surgery.
- You have not had chemotherapy or other treatments for metastatic pancreatic cancer before, but you may have had treatment before it spread.
- You have at least one tumor that can be measured on a scan.
- You are able to care for yourself (ECOG score 0-1) and expected to live at least 6 months.
- Your blood counts, liver, kidney, and heart function are within acceptable levels.
- You do not have an active autoimmune disease, severe heart problems, active infections like hepatitis B or C, or other cancers in the past 5 years (except for very low-risk ones).
- You are willing to use reliable birth control if you are able to have children.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new combination of two drugs for advanced pancreatic cancer. It aims to see if adding an immunotherapy drug (which helps your immune system attack cancer) to standard chemotherapy can help control the cancer better.
This study tests a personalized vaccine made from your tumor's unique markers. It aims to help your immune system attack pancreatic cancer that has spread or returned.
This study tests a personalized vaccine made from your own tumor, combined with a drug that helps your immune system fight cancer cells. The goal is to see if this approach can help prevent your pancreatic cancer from coming back after surgery.
This trial tests a personalized mRNA vaccine (made from your tumor's unique markers) combined with standard chemotherapy after surgery for pancreatic cancer. The goal is to see if the vaccine can help prevent the cancer from coming back.
This early-stage trial tests a personalized immune “vaccine” made from dendritic cells, given alongside standard chemotherapy for pancreatic cancer that may be removable by surgery (resectable or borderline resectable). If it works, it may help your immune system better recognize and attack the cancer around the time of treatment.
This trial combines a new vaccine (XH001) with chemotherapy after surgery for pancreatic cancer. The vaccine aims to train your immune system to fight any remaining cancer cells, potentially lowering the chance of the cancer coming back.
Hear when a new Pancreatic Cancer Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.